Skip to Content
Merck

HPLC Analysis of mAb-X22 on Antibodix® WCX-NP10, Impact of Initial Salt Concentration

HPLC Analysis of mAb-X22 on Antibodix® WCX-NP10, Impact of Initial Salt Concentration application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Antibodix® WCX-NP10 Weak Cation Exchange Column

L × I.D. 25 cm × 4.6 mm, 10 μm particle size

CONDITIONS

column

Antibodix WCX-NP10, 25 cm x 4.6 mm I.D., 10 μm particles (Z777272)

mobile phase

(A) 10 mM sodium phosphate buffer, pH 7.5; (B), A + 100 mM NaCl

gradient

15 to 65% B in 60 min

flow rate

0.8 mL/min

column temp.

25 °C

detector

UV, 214 nm

injection

10 μL

sample

MAb-X22, 1.5 mg/mL

Description

Legal Information

Antibodix is a registered trademark of Sepax Technologies